Nothing Special   »   [go: up one dir, main page]

Engel et al., 1998 - Google Patents

Expression level of a transgenic λ2 chain results in isotype exclusion and commitment to B1 cells

Engel et al., 1998

View PDF
Document ID
15801334035442946840
Author
Engel H
Bogen B
Müller U
Andersson J
Rolink A
Weiss S
Publication year
Publication venue
European Journal of Immunology

External Links

Snippet

Two new λ2 chain‐transgenic mouse lines were established, both of which showed stable transgene expression during aging of the mice. The line L23, which expressed the transgene at low levels, exhibited normal B cell development, antibody responses and …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals

Similar Documents

Publication Publication Date Title
Okamoto et al. A transgenic model of autoimmune hemolytic anemia.
Schwartzberg et al. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations
Tarakhovsky et al. Lymphocyte populations and immune responses in CD5‐deficient mice
Kline et al. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional μ heavy chains
Tiegs et al. Receptor editing in self-reactive bone marrow B cells.
Pewzner-Jung et al. B cell deletion, anergy, and receptor editing in “knock in” mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain
Santulli-Marotto et al. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens
Shlomchik et al. A rheumatoid factor transgenic mouse model of autoantibody regulation
Schönrich et al. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen
Cao et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Becker et al. Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice
Bogen et al. A rearranged λ2 light gene chain retards but does not exclude x and λ1 expression
Hasan et al. Incomplete block of B cell development and immunoglobulin production in mice carrying the μ MT mutation on the BALB/c background
Chumley et al. A VH11Vκ9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro
Reap et al. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice.
JP2009100765A (en) TRANSGENIC ANIMAL BEARING HUMAN Iglambda LIGHT CHAIN GENE
Mountz et al. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.
Martin et al. Development of VH81X transgene-bearing B cells in fetus and adult: sites for expansion and deletion in conventional and CD5/B1 cells.
Itoh et al. Deletion of bone marrow stromal cell antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-induced IgG3 and mucosal TD antigen-elicited IgA responses
Engel et al. Expression level of a transgenic λ2 chain results in isotype exclusion and commitment to B1 cells
Reap et al. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy.
Tsao et al. B cells are anergic in transgenic mice that express IgM anti‐DNA antibodies
Carmack et al. Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA (Sb) determinant on influenza virus.
Salmon et al. Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes.
Müller et al. Membrane‐bound IgM obstructs B cell development in transgenic mice